Literature DB >> 25516362

Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients.

B Shuai1, Y P Yang, L Shen, R Zhu, X J Xu, C Ma, L Lv, J Zhao, J H Rong.   

Abstract

UNLABELLED: The local renin-angiotensin system (RAS) is closely related to bone metabolism. However, it is unknown whether the local RAS is related to bone mineral density (BMD) in glucocorticoid-induced osteoporosis (GIOP). Here, we revealed that the two main characteristics of GIOP might inhibit bone formation and enhance bone resorption.
INTRODUCTION: The aim of this study is to assess the expression of the main RAS components in the trabecular bone of lumbar vertebrae in GIOP and analyze the relationship between the major RAS components and BMD.
METHODS: We collected 96 inpatient cases of lumbar disc herniation from patients who underwent dual-energy X-ray absorptiometry examinations followed by surgical treatment in our hospital. Patients were divided into the GIOP group (n = 48) and control group (n = 48). The circulating and local expression levels of the main RAS components were examined. The correlation between the main RAS components and BMD was then analyzed.
RESULTS: The mRNA expression of local bone angiotensin type 1 and 2 receptors (AT1R and AT2R, respectively) and RANKL was higher in the GIOP group compared with the control group (p < 0.001), but there was no difference in the circulating protein levels between groups (p > 0.05). Multiple logistic regression analysis revealed that AT1R and AT2R expression and the RANKL/OPG ratio in local bone were negatively associated with BMD (p < 0.001, odds ratio (OR) 1.236, 95 % confidence interval (CI) 1.207-1.333; p < 0.001, OR 1.971, 95% CI 1.809-2.233; and p < 0.001, OR 1.676, 95% CI 1.546-1.845, respectively).
CONCLUSION: This study provides evidence that the role of local RAS is related to BMD in GIOP patients, and suggests that local RAS might influence RANKL/OPG signaling to modulate bone metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25516362     DOI: 10.1007/s00198-014-2992-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  27 in total

Review 1.  Fluid shifts due to microgravity and their effects on bone: a review of current knowledge.

Authors:  Ian D McCarthy
Journal:  Ann Biomed Eng       Date:  2005-01       Impact factor: 3.934

2.  Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells.

Authors:  H Hagiwara; Y Hiruma; A Inoue; A Yamaguchi; S Hirose
Journal:  J Endocrinol       Date:  1998-03       Impact factor: 4.286

Review 3.  Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.

Authors:  Dilek Iusuf; Robert H Henning; Wiek H van Gilst; Anton J M Roks
Journal:  Eur J Pharmacol       Date:  2008-03-15       Impact factor: 4.432

4.  Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro.

Authors:  R Hatton; M Stimpel; T J Chambers
Journal:  J Endocrinol       Date:  1997-01       Impact factor: 4.286

Review 5.  A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.

Authors:  S Lekamwasam; J D Adachi; D Agnusdei; J Bilezikian; S Boonen; F Borgström; C Cooper; A Diez Perez; R Eastell; L C Hofbauer; J A Kanis; B L Langdahl; O Lesnyak; R Lorenc; E McCloskey; O D Messina; N Napoli; B Obermayer-Pietsch; S H Ralston; P N Sambrook; S Silverman; M Sosa; J Stepan; G Suppan; D A Wahl; J E Compston
Journal:  Osteoporos Int       Date:  2012-03-21       Impact factor: 4.507

6.  Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway.

Authors:  Sreerupa Ghose Roy; Priyanka De; Debasri Mukherjee; Vivek Chander; Aditya Konar; Debasish Bandyopadhyay; Arun Bandyopadhyay
Journal:  Cell Physiol Biochem       Date:  2009-07-01

7.  Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension.

Authors:  A Sato; H Suzuki; Y Nakazato; H Shibata; T Inagami; T Saruta
Journal:  J Hypertens       Date:  1994-05       Impact factor: 4.844

8.  Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis.

Authors:  Zhang Yongtao; Wang Kunzheng; Zheng Jingjing; Shan Hu; Kou Jianqiang; Liu Ruiyu; Wang Chunsheng
Journal:  Endocrine       Date:  2014-02-12       Impact factor: 3.633

9.  Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.

Authors:  Lars Rejnmark; Peter Vestergaard; Leif Mosekilde
Journal:  J Hypertens       Date:  2006-03       Impact factor: 4.844

10.  Angiotensin II type 2 receptor blockade increases bone mass.

Authors:  Yayoi Izu; Fumitaka Mizoguchi; Aya Kawamata; Tadayoshi Hayata; Testuya Nakamoto; Kazuhisa Nakashima; Tadashi Inagami; Yoichi Ezura; Masaki Noda
Journal:  J Biol Chem       Date:  2008-11-11       Impact factor: 5.157

View more
  8 in total

1.  Identification of a Potential MiRNA-mRNA Regulatory Network for Osteoporosis by Using Bioinformatics Methods: A Retrospective Study Based on the Gene Expression Omnibus Database.

Authors:  Shi Lin; Jianjun Wu; Baixing Chen; Shaoshuo Li; Hongxing Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-10       Impact factor: 6.055

2.  Assessment of the Impact of Zoledronic Acid on Ovariectomized Osteoporosis Model Using Micro-CT Scanning.

Authors:  Bo Shuai; Lin Shen; Yanping Yang; Chen Ma; Rui Zhu; Xiaojuan Xu
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

3.  Effects of 1,25-dihydroxyvitamin D3 on the local bone renin-angiotensin system in a murine model of glucocorticoid-induced osteoporosis.

Authors:  Lin Shen; Chen Ma; Bo Shuai; Yanping Yang
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

4.  Activation of (pro)renin by (pro)renin receptor in extracellular vesicles from osteoclasts.

Authors:  Jonathan B Murray; Christy Mikhael; Guanghong Han; Lorraine Perciliano de Faria; Wellington J Rody; L Shannon Holliday
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

Review 5.  Angiotensin Receptor Blocker is Associated with a Lower Fracture Risk: An Updated Systematic Review and Meta-Analysis.

Authors:  Jing Wu; Mei Wang; Man Guo; Xin-Yi Du; Xiao-Zhen Tan; Fang-Yuan Teng; Yong Xu
Journal:  Int J Clin Pract       Date:  2022-07-14       Impact factor: 3.149

6.  Tripeptide IRW Protects MC3T3-E1 Cells against Ang II Stress in an AT2R Dependent Manner.

Authors:  Nan Shang; Khushwant S Bhullar; Jianping Wu
Journal:  Molecules       Date:  2022-06-08       Impact factor: 4.927

7.  Analysis of the prevalence, risk factors, and clinical characteristics of osteoporosis in patients with essential hypertension.

Authors:  Hai-Long Wu; Jie Yang; Yu-Chi Wei; Jian-Yu Wang; Yu-Yan Jia; Luan Li; Lu Zhang; Yan Lu; Zong-Jian Luo; Xiang-Yang Leng
Journal:  BMC Endocr Disord       Date:  2022-06-27       Impact factor: 3.263

8.  The Embryonic Chick Femur Organotypic Model as a Tool to Analyze the Angiotensin II Axis on Bone Tissue.

Authors:  Thais Francini Garbieri; Victor Martin; Carlos Ferreira Santos; Pedro de Sousa Gomes; Maria Helena Fernandes
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.